LG Chem to supply filters for Israel's large-scale water desalination plant

채사라 2023. 5. 18. 14:39
글자크기 설정 파란원을 좌우로 움직이시면 글자크기가 변경 됩니다.

이 글자크기로 변경됩니다.

(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.

LG Chem has been chosen to provide filters for Israel's one of the five largest projects to turn seawater into fresh water. The company said it has been selected as the sole supplier of 30,000 reverse osmosis membranes.
The seawater desalination plant in Israel where LG Chem will supply its reverse osmosis is pictured. [LG CHEM]

LG Chem has been chosen to provide filters for Israel's one of the five largest projects to turn seawater into fresh water.

The chemical company said it has been selected as the sole supplier of 30,000 reverse osmosis membranes to a seawater desalination plant co-owned by Shapir, an Israeli engineering company, and wastewater firm GES.

Reverse osmosis is a process that removes solids such as salt from water.

"The Ashdod Rehabilitation Project is one of the five largest desalination plants in Israel," LG Chem said. "The 30,000 reverse osmosis membranes is enough to turn around 100 million tons of seawater into fresh water every year, equivalent to the amount of water needed for around 1.1 million people."

The membranes are slated to be commissioned by mid-2024.

LG Chem's reverse osmosis membranes deliver the industry's highest level of salt rejection with the ability to remove 99.85 percent of salts from the water, it said.

LG Chem has been expanding its filter business globally with its reverse osmosis membranes. Around 1.86 billion tons of water have been turned into fresh water through the company's products worldwide. That is approximately 5.1 million tons per day.

The world's wastewater filter market is expected to grow at an annual rate of 3.9 percent to reach 6.4 trillion won ($4.8 billion) by 2024, according to data by Global Water Intelligence.

BY SARAH CHEA [chea.sarah@joongang.co.kr]

Copyright © 코리아중앙데일리. 무단전재 및 재배포 금지.

이 기사에 대해 어떻게 생각하시나요?